AKT1 and lung carcinoma: We found that A939572 could significantly impair the phosphorylation of EGFR/PI3K/Akt signaling, and parallelly suppressed the cell vitality, apoptosis in vitro and tumor growth in vivo of lung cancer cells to restore the sensitivity to Gefitinib.